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Abstract
Bacterial ghosts that are generated using the regulated PhiX174 lysis gene E offer a new avenue for the study of
inactivated vaccines. Here, we constructed a library of mutant gene E using a gene-shuffling technique. After
screening and recombination with the prokaryotic non-fusion expression vector pBV220, two lysis plasmids were
selected. Among which, a novel mutant E gene (named mE), consisting of a 74-bp non-encoding sequence at
5’-end and a 201-bp gene ΔE, significantly increased the lysis effect on prokaryotic Escherichia coli and Salmonella
enteritidis. Moreover, lysis efficiency, as measured by the OD600 value, reached 1.0 (10
9 CFU), avoiding the
bottleneck problem observed with other bacterial lysis procedures, which results in a low concentration of bacteria
in suspension, and consequent low production of bacterial ghosts. Our results may provide a promising avenue for
the development of bacterial ghost vaccines.
Introduction
The lysis gene E of coliphage PhiX174 encodes a 91-
amino acid (aa) residue protein of approximately 10 kDa
that mediates inhibition of peptidoglycan biosynthesis of
Gram-negative bacteria membrane[1]. This facilitates
lysis from changes in osmotic pressure, leaving an
empty bacterial body lacking cytoplasm and nucleic
acids, which is called a bacterial ghost (BG) [2]. BGs
retain an intact bacterial surface structure and inte-
grated antigen proteins, and can be generated without
harsh physical or chemical inactivation methods. BGs
can be used directly as vaccines, as they exhibit good
immunogenicity and provide effective inducible immu-
noprotection. Furthermore, inserting the exogenous
antigen protein into the outer, inner, or periplasmic
membranesis is relatively simple, and genetic engineer-
ing can be used to construct recombinant multivalent
BG vaccines. Thus, BGs have been widely applied in the
development of new vaccines [3-5].
I nap r e v i o u ss t u d y ,w ec o n s t r u c t e dal y s i sp l a s m i d
pBV-E from the PhiX174 lysis gene E and the plasmid
pBV220. Upon transformation of E. coli strain DH5a,
lysis efficiency was 98%. Using parameters from previous
studies, the optical density (OD) value at 600 nm of the
bacterial suspension was maintained at 0.4 (10
6 CFU) by
adding chloramphenicol (50 μg/mL) to inhibit bacterial
proliferation [6]. Nonetheless, low lysis efficiency and
ghost production have been the key technical obstacles
that have prevented the large-scale production and
industrialization of BG vaccines.
To address these technical problems, the current study
focused on the function of the bacteriophage PhiX174
lysis gene E. Mutations were introduced by gene shuf-
fling, and after screening and recombination with the
pBV220 vector, novel mutants of lysis E gene (named
mEs) were selected and the lysis plasmid pBV-mEs were
characterized. Plasmids pBV-mEs may be a useful tool
for producing BGs of Gram-negative bacteria such as
E. coli and Salmonella enteriditis.
Materials and methods
Plasmids and bacterial strains
Plasmid pBV220 was a kind gift from Professor Gui-
hong Zhang of South China Agricultural University. It is
a prokaryotic non-fusion expression vector with multiple
cloning sites (MCS) adjacent with Shine-Dalgarno (SD)
sequence, and a high-copy number plasmid with a gene
for ampicillin resistance and a lPL/PR-cI857 tempera-
ture-sensitive system that can express target gene
inserted in MCS at 42°C (Figure 1). E. coli strain JL09
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fied in our lab. Bacteriophage PhiX174 was purchased
from NEB (Beverly, MA). E. coli strain DH5a was main-
tained in our laboratory.
Cloning of bacteriophage PhiX174 lysis gene E
Primers were designed according to the sequence of
PhiX174 lysis gene E [7] in Genbank and synthesized by
Invitrogen Inc. (Shanghai). Upstream primer LysisE-U:
5’-AGG GAA TTC ATG GTA CGC TGG ACT TTG
TGG-3’(EcoR I restriction site was underlined), down-
stream primer LysisE-L: 5’-AGG GGA TCC GAG CTC
TCA CTC CTT CCG-3’(BamH I restriction site was
underline). Gene E was amplified using PhiX174 double-
stranded DNA as template, in a 50 μL reaction with
amplification cycle parameters: 5 min at 95°C; 30 cycles
of 30 s at 94°C, 30 s at 59°C, 1 min at 72°C, 5 min at 4°
C. PCR products were resolved on 0.9% agarose gels,
and the 300-bp gene E fragment was extracted with a
gel extraction kit (Shanghai Watson Biotech Co., China).
DNA shuffling in lysis gene E
DNA shuffling was carried out according to Evans [8]
with minor modifications. The purified gene E was
digested with DNase I and fragments of 10-50 bp were
gel-purified and amplified by primerless PCR. Reaction
parameters were: 45 cycles of 94°C for 30 s, 40°C for
30 s, and 72°C for 30 s. PCR products were analyzed on
a 2% agarose gel and used as PCR templates using
LysisE-U and LysisE-L as primers, with parameters: 95°C
for 5 min; 30 cycles of 94°C for 30 s, 59°C for 30 s, 72°C
for 30 s, and extension at 72°C for 5 min. Products were
resolved on 0.9% agarose gels and extracted as above.
Construction, screening, and transformation of clinical
strains and lysis plasmid library efficiency comparison
Purified EcoRI -a n dBamH I-digested fragments of
mutant gene E were inserted into pBV220 and trans-
formed into DH5a competent cells, which were spread
on LB plates containing ampicillin. Single colonies were
picked and screened by colony PCR with primers
LysisE-U and LysisE-L. Positive clones were cultured at
37°C and sent to Invitrogen Inc. (Shanghai) for sequen-
cing. Expression of lysis gene E or mutants of E was
induced at 42°C. After bacteriolysis, the bacterial sus-
pension was diluted to an appropriate concentration and
spread on LB containing ampicillin. After 37°C for 12 h,
colonies were counted and the results expressed as
CFU/ml. The lysis rate was calculated using the follow-
ing formula: lysis rate = (1- CFU after induction/CFU
before induction) × 100%. Plasmids with high lysis rates
were selected and sequenced, and those with the highest
lysis rate were electroporated into the clinically isolated
bacterial strains E. coli JL09 and S. enteriditis DH09.
Analysis, and calculation and comparison of lysis rates
used the protocol above. The corresponding bacterial
strain harboring pBV220 was used as control.
Scanning electron microscopy (SEM) and transmission
electron microscopy (TEM)
Sample preparation for SEM (model, JSM-6510LV,
Japan) was by centrifugation of a induced bacterial sus-
pension at 3000 × g for 10 min, before fixing with 2.5%
glutaraldehyde (pH 7.2) for 1.5 h at 4°C. Samples were
washed three times for 10 min with 0.01 M phosphate-
buffered saline (PBS). Dehydration steps were 10 min
each in 50%, 70%, 80%, and 90% ethanol, a 1:1 mixture
of 100% ethanol and tert-butanol, and pure tert-butanol.
After lyophilization for approximately 4 h, samples were
placed on the microscope platform, coated with a layer
of heavy metal and examined.
Sample preparation for TEM (microscope model, JEM
1200 EX, Japan) was as above, except fixing was for 2-3 h.
Samples were washed as above, and fixed with 2% osmic
acid for 1.5 h, followed by three washings of 10 min each
with 0.1 M PBS. Dehydration steps were 10 min each in
50%, 70%, 80%, 90%, and 100% ethanol. Samples were
immersed in 1:1, 1:2, or 1:3 mixtures of SPI-Pon 812 resin
(emicron) and acetone, before immersing overnight in
Figure 1 Physical map of prokaryotic non-fusion expression
vector pBV220. Ampr, ampicillin resistance gene; ori, replication
origin; cIts857, restraining gene of lambda bacteriophage adapted
to heat induced expression; PRPL, tandem promoters of lambda
bacteriophage for the high level expression; SD, Shine-Dalgarno
sequence; rrnB, ribosome rrnB gene providing translation stop
signal; and EcoRI and BamHI, restriction enzyme sites to insert
mutant lysis E gene into vector.
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merized at 70°C for 48 h, and samples sectioned and
stained with uranyl acetate and lead citrate, before
microscopy.
Results
PCR amplification of lysis gene E and DNA shuffling
The size of the PCR-amplified lysis gene E fragment was
276 bp, as expected (Figure 2A1). The purified fragment
was digested with DNase I, and the digested fragments
ran as a smear (Figure 2A2). Fragments of 10-50 bp
were gel-purified and amplified by primerless PCR, and
appeared as diffuse bands of 100-300 bp on a 1% agar-
ose gel (Figure 2A3). Primerless PCR products were
used as a template for primed PCR amplification, yield-
ing a single 276-bp band on a 1% agarose gel. This band
was the shuffled, mutated gene E (Figure 2A4).
Shuffled gene E lysis plasmids, and screening of high
lysis efficiency plasmids
Gel-purified mutants fragments were digested with EcoR
Ia n dBam H I and inserted into the vector pBV220,
and transformed into E. coli DH5a. Selection on LB
containing ampicillin generated a lysis plasmid library of
gene E mutants.
After large-scale screening, six stable strains were
obtained. Lysis plasmids No. 3 (p3) and No. 4 (p4) had
the highest lysis rates, at 99.999%. No lysis was observed
in control group pBV220. Sequencing and comparison
indicated that p3 and p4 share 100% identity with each
other and share 98% identity with pBV-E and other four
non-lysis plasmids (Figure 2B). A single nucleotide dele-
tion was found at the 5’-end of the lysis gene E
sequence in mE3 and mE4, which converts the original
wild-type E gene into a 74-bp non-coding region and a
201-bp gene ΔE. Then ΔE was amplified and inserted
into EcoR I- and BamH I sites, the plasmid pBV-ΔE had
lysis rate of 56.427%.(Figure 2C) Thus, this 74-bp region
is likely to play an important role in lysis enhancement.
We further investigated plasmid p4 (named pBV-mE),
which had the highest lysis rates.
Comparison of the pBV-mE transformed E. coli lysis curve
at different OD values
The results of lysis kinetics experiments showed that
pBV-mE had very high lysis efficiency against DH5a
Figure 2 DNA shuffling of gene E (A), nucleotide and amino acid sequences(B) and lysis efficiency comparisons of two high-efficiency
lysis plasmids and four non-lytic plasmids (C). A1: 276 bp lysis gene E amplified from bacteriophage PhiX174. A2: Electrophoresis of the DNA
fragments generated from DNase I digestion of the lysis gene E fragment. A3: Primerless PCR products. A4: Primer PCR products. B: Sequence
comparison of the recombinant plasmids. Mutant sites were boxed; deletion sites were signed with strigula. C: lysis efficiency comparisons of the
recombinant plasmids. pBV-E, pBV-ΔE: lysis gene E and ΔE was inserted into EcoR I- and BamH I sites of pBV220, respectively; control: pBV220
Yu et al. Virology Journal 2011, 8:206
http://www.virologyj.com/content/8/1/206
Page 3 of 6cells. Effective lysis occurred at all tested OD values (0.4,
0.6, 0.8 and 1.0), and progressed rapidly, with lysis com-
pleted within 2 h (Figure 3).
Comparison of lysis efficiencies of clinically isolated
bacteria transformed with pBV-mE
Plasmid pBV-mE had the same lysis effect on both
E. coli and S. enteriditis. Comparison of SEM and TEM
photographs of the cell surface of E. coli and S. enteridi-
tis b e f o r ea n da f t e rl y s i ss h o w e dt h a tB G sr e t a i n e dt h e
basic cell morphology of the bacterial cells, but dis-
played obvious surface wrinkles from the loss of intra-
cellular contents. Arrow c in Figure 4E, and arrow d in
Figure 4F indicate lysis tunnels in the S. enteriditis BGs,
located mainly at the cell poles. Ejection of the intracel-
lular contents from the lysis tunnels can be seen, consis-
tent with a previous report [9], although the BGs in our
study exhibited relatively complete outer membranes
with little change in morphology.
Discussion
Genetic inactivation of Gram-negative bacteria by indu-
cing a regulated bacteriophage PhiX174 lysis gene E
provides a new avenue for inactivated vaccine research
[4,10]. E-protein-mediated lysis has already been used to
investigate many types of bacterial ghosts, suggesting
that it may be applicable to any of the Gram-negative
bacteria [3,11-16]. Moreover, bacterial ghosts can be
used as vehicles for the delivery of exogenous antigens
or drugs.
In this study, a 275-bp mE gene was selected from a
library of mutant lysis gene E generated by DNA shuf-
fling. The mutant contained a 74-bp non-encoding
sequence and a 201-bp lysis gene ΔE. A lysis plasmid
containing the mE gene driven by dual pR and pL
promoters significantly increased lysis efficiency over the
95% efficiency in the same E. coli strain with previously
reported constructs with a single pR or pL promoter
[17]. The lysis efficiency of the plasmids was not
affected by bacterial concentration. Bacteria with an
OD600 of 1.0 (10
9cfu) are sufficiently concentrated for
vaccination, and the observed 99.999% lysis efficiency of
pBV-mE was higher than another lysis plasmid, pBV-E
(98%) that we previously generated [6]. The new lysis
plasmid eliminates the lysis requirement that the OD of
the bacterial culture be between 0.4 and 0.6, which has
been a key technical problem for large-scale vaccine
production. Therefore, the current data indicate a pro-
mising avenue for BG vaccine research.
While both E. coli and Salmonella showed good lysa-
bility, the lysis efficiency of protein mE was significantly
higher than lysis protein E in both bacteria. Previous
studies showed that the N-terminal 51 aa of PhiX174
lysis protein E are necessary for lysis activity [18] and
the lysis activity localized to the N-terminal 29 aa [19].
Figure 3 T h el y s i sc u r v eo fE. coli DH5a cells containing pBV-
Me. The lysis curve of DH5a containing pBV-mE at (A) OD600 = 0.4,
(B) OD600 = 0.6, (C) OD600 = 0.8, (D) OD600 = 1.0
Figure 4 Electron microscopy analysis of E. coli and S.
enteriditis before and after lysis. A: Morphology of wild-type E.
coli under scanning electron microscopy: intact and healthy. B:
Morphology of E. coli after lysis under scanning electron
microscopy: shrinkage observed. C: Morphology of wild-type S.
enteriditis under transmission electron microscopy: even electron
density. D: Morphology of S. enteriditis ghosts after lysis under
transmission electron microscopy: uneven electron density, vacuolar.
E, F: Observation of the ejection of the intracellular contents from S.
enteriditis under transmission electron microscopy. a. S. enteriditis
before lysis (12,000 × magnification). b. S. enteriditis after lysis,
bacterial ghost (12,000 ×). c. Lysis tunnels on ghosts (12,000 ×). d.
Lysis tunnels on ghosts (30,000 ×)
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with the N-terminal 35 aa, including a hydrophobic area
(a potential transmembrane region) that is essential for
the lysis function of protein E [20]. The C-terminus of
protein E is important for conformational stability and
regulation of lysis functions [21]. It was proposed that,
at an early stage of bacteriolysis, a conformational iso-
merism probably occurs at proline residue 21 (P21) in
the first transmembrane a-helix of protein E. Mutations
of P21 to alanine, glycine, serine, or valine result in an
unstable protein, and thus affect E protein levels in vivo
and the loss of lysis function. The initiation of cell divi-
sion, rather than any specific functions of the septotome
has been shown to play a pivotal role in protein E-
mediated Gram-negative bacteriolysis [22].
It is interesting that our results differ from those of
previous studies. For plasmid p1 and p6 with observed
enhancement of lysis effect, single deletion of A from
the 5’-end of E gene converted the first 75-bp encoding
sequence to 74-bp non-encoding region, which resulted
in the loss of first 25 aa in wild-type E protein. Consid-
ering the length of the mE protein is sufficient for cross-
ing the membrane, we propose that lysis activity is not
located only within the first 29 aa of protein E, but
rather that sequences downstream of aa 25 also have
lysis activity. However, so far as now, the detailed
mechanism of E-mediated lysis is still obscure, let alone
the mE protein. Therefore, we would work on the
assumption as follows.
It should be pointed out that, after sequence compari-
son, we found the similarity of this 74-bp sequence with
many well-known viral enhancers (Figure 5). Moreover,
the first five bases (TGGTA) of the 74-bp is only one
nucleotide different from the minus-35 region of the
RpoN (alternate sigma factor) consensus (TGGCA). It is
also only one nucleotide different from the minus-35
sequence of the strong promoter of the recA gene
(TGATA). Therefore, one possible explanation for this
enhancement is that the 74-bp sequence dramatically
improves the transcription efficiency of pBV-mE,
increases production of the ΔE protein and provides
excess protein molecule for lysis. Another explanation is
the 74-bp sequence may positively regulate the replica-
tion of lysis plasmids pBV-mEs. All lysis plasmids con-
structed with mutant E genes (pBV-mEs) had copy
numbers higher than that of pBV-E (data not shown).
Lin et al. reported that copy numbers of pUC family
plasmids are much higher than other plasmids with a
pMB1 or colE1 origin. This is due to a single point
mutation in the pUC plasmids that can cause a tem-
perature-dependent alteration in the secondary structure
of RNA II[23].
In conclusion, the results from our study could indi-
cate a potentially new avenue to solve two key problems
in BG research and vaccine production: low bacterial
concentration and low BG production. More work is
needed to confirm the above assumptions about mE
gene. Identification and characterization of 74-bp
enhancer or enhance-like or promoter-like element is
carrying out.
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